Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?7.00
 
WKN: A3MQR6 / Name: Viromed Medical / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Viromed Medical AG Stock

The community is currently still undecided about Viromed Medical AG with 1 Buy predictions and 1 Sell predictions.
As a result the target price of 7 € shows a very positive potential of 65.88% compared to the current price of 4.22 € for Viromed Medical AG.

Pros and Cons of Viromed Medical AG in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Viromed Medical AG: MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026
Viromed Medical AG: MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026


On 12 February 2026, Hannover Medical School (MHH) – represented by Prof. Dr. Hortense Slevogt – plans to hold a press conference together with the team from the Helmholtz Centre for Infection

EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed Medical AG switches to registered shares
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation
EQS-News: Viromed AG: Strategic Update on Operational Focus and Value Creation